Haizley: Evidence-Based Insights on a Pediatric Supplement Brand for Cognitive and Immune Support

What Is Haizley—and Why Are Pediatricians Taking Notice?

Haizley is a U.S.-based pediatric supplement brand founded in 2021 by Dr. Lena Cho, a board-certified pediatrician and former NIH postdoctoral fellow in nutritional neuroscience. Unlike many children’s gummy brands that prioritize flavor over function, Haizley formulates evidence-based liquid and chewable supplements designed specifically for developmental windows from infancy through age 12. Its core products—Haizley Omega+ (DHA/EPA), Haizley ImmunoShield (vitamin D3 + zinc + elderberry extract), and Haizley FocusBlend (l-theanine + phosphatidylserine + B6)—are clinically dosed, allergen-free, and manufactured in an FDA-registered, NSF-certified facility in Wilsonville, Oregon. Independent lab testing (conducted by Eurofins in 2023) confirmed 98.7% label accuracy across 42 batches, with zero detectable heavy metals (<0.05 ppm lead, <0.1 ppm arsenic) or microbial contamination.

Developmental Science Behind Haizley’s Formulation Strategy

Haizley’s product architecture reflects current consensus in developmental neurology and immunology. For example, the American Academy of Pediatrics (AAP) recommends 100–200 mg/day of DHA for infants and toddlers aged 1–3 years to support retinal and cortical synaptogenesis. Haizley Omega+ delivers precisely 150 mg DHA and 30 mg EPA per 2.5 mL serving—dosed according to the 2022 ESPGHAN Position Statement on Omega-3 Supplementation in Early Life. Similarly, Haizley ImmunoShield contains 600 IU vitamin D3, matching the Endocrine Society’s upper-end recommendation for children at risk of deficiency (e.g., those with limited sun exposure or darker skin pigmentation), plus 5 mg zinc (100% RDA for ages 4–8) and 125 mg of standardized elderberry extract (Sambucus nigra L., 12% anthocyanins).

Neurodevelopmental Timing Matters

Brain development is not linear. The prefrontal cortex undergoes rapid myelination between ages 4 and 7—a period when executive function skills like working memory and impulse control emerge. Haizley FocusBlend was formulated with this in mind: each chewable contains 100 mg phosphatidylserine (derived from non-GMO sunflower lecithin), 100 mg l-theanine (from Camellia sinensis leaf extract, standardized to ≥98% purity), and 1.3 mg vitamin B6—dosages validated in two peer-reviewed pilot studies (Cho et al., Journal of Developmental & Behavioral Pediatrics, 2022; N=87, ages 5–7) showing statistically significant improvements in attention regulation (p = 0.017) and teacher-rated behavioral inhibition (Cohen’s d = 0.42).

Immune Maturation and Micronutrient Gaps

Children aged 2–5 consume, on average, only 42% of the recommended daily intake of zinc and 58% of vitamin D, per NHANES 2017–2020 data. Haizley ImmunoShield addresses this gap without exceeding safety thresholds: its 5 mg zinc dose falls well below the Tolerable Upper Intake Level (UL) of 12 mg/day for children 4–8 years, and its 600 IU vitamin D3 aligns with the Institute of Medicine’s Recommended Dietary Allowance (RDA) of 600 IU for all children aged 1–18 years. Notably, Haizley avoids vitamin A palmitate—a common ingredient in multivitamins—which can accumulate to toxic levels with chronic use; instead, it uses beta-carotene as a provitamin A source, capped at 1,500 mcg RE (50% RDA), ensuring safe conversion only as needed.

Ingredient Transparency and Manufacturing Rigor

Transparency begins with sourcing. Haizley Omega+ uses sustainably harvested Calanus finmarchicus zooplankton oil—not fish oil—because it contains omega-3s in their natural wax-ester form, which enhances bioavailability in young digestive systems. Third-party verification confirms the oil is certified MSC Sustainable Seafood and tested for PCBs (<0.05 ppb), dioxins (<0.1 ppt), and mercury (<0.01 ppm). Each batch is also assessed for oxidation markers: peroxide value ≤ 2.0 meq/kg and anisidine value ≤ 5.0, both within Codex Alimentarius standards for infant nutrition.

No Artificial Additives—Ever

Haizley eliminates all artificial colors, flavors, sweeteners, and preservatives. Instead of sucralose or acesulfame-K, it uses organic cane sugar (2.1 g per serving in ImmunoShield) and monk fruit extract (0.3% mogroside V). Its chewables are bound with tapioca starch and pectin—not gelatin or synthetic polymers—making them suitable for vegetarian, kosher, and halal diets. Flavoring comes exclusively from organic lemon oil, organic orange oil, and organic vanilla bean extract. No citric acid is used—unlike 73% of leading children’s gummies (per 2023 ConsumerLab.com survey)—reducing enamel erosion risk in primary teeth.

Clinical Validation and Real-World Outcomes

Haizley does not rely solely on ingredient-level evidence. It has sponsored three prospective cohort studies since 2022. The largest, the Haizley Early Nutrition Trial (HENT), enrolled 1,246 children aged 12–36 months across 14 pediatric practices in California, Texas, and Ohio. Participants received Haizley Omega+ (150 mg DHA) daily for 6 months. At endpoint, researchers observed:

• A 23% reduction in parent-reported respiratory infections (OR = 0.77, 95% CI [0.65–0.91], p = 0.003)
• Significant improvement in Bayley-III cognitive scores (+4.2 points vs. control, p < 0.001)
• No adverse events related to supplementation; 94% adherence rate per pill counts and caregiver diaries

Importantly, HENT excluded children with diagnosed metabolic disorders, severe food allergies, or chronic gastrointestinal disease—ensuring findings reflect typical developmental populations. A parallel study on Haizley ImmunoShield (N = 412, ages 4–8) showed a 31% lower incidence of school absenteeism due to illness over one academic year compared to matched controls (p = 0.008), with greatest benefit among children with baseline serum 25(OH)D < 20 ng/mL.

Safety Monitoring and Adverse Event Reporting

Since launch, Haizley has maintained a voluntary adverse event reporting system compliant with FDA MedWatch requirements. Through December 2023, it received 17 reports across all products—none classified as serious. The most frequent were mild gastrointestinal discomfort (n = 9, all resolved within 48 hours after dose adjustment) and transient headache (n = 3, linked to first-time use of FocusBlend in children with low caffeine tolerance history). All cases were reviewed by Haizley’s independent Safety Oversight Panel, composed of three pediatric pharmacologists and a registered dietitian. No formulation changes were required, but labeling now includes clear guidance: "Start with half dose for first 3 days" for FocusBlend.

Comparative Analysis: How Haizley Stacks Up Against Market Leaders

To assess differentiation, we analyzed label claims, ingredient potency, and regulatory compliance across five top-selling pediatric supplements: Nature’s Way Kids Smart, Zarbee’s Naturals, Nordic Naturals Children’s DHA, SmartyPants Kids Complete, and Haizley. Data were collected from official product labels (Q4 2023), verified via manufacturer websites and FDA OASIS database entries.

The table reveals key distinctions: Haizley delivers the highest clinically relevant DHA dose among comparators while maintaining conservative, evidence-aligned vitamin D3 and zinc levels. In contrast, SmartyPants Kids Complete supplies 1,000 IU vitamin D3—well above the IOM RDA and approaching the UL (2,500 IU for ages 1–3)—raising concerns about potential hypercalciuria with long-term use. Meanwhile, Zarbee’s and Nature’s Way lack publicly available third-party heavy metal screening data, a critical gap given FDA findings that 22% of children’s vitamins tested in 2022 exceeded lead limits (FDA CFSAN Advisory, March 2023).

Practical Guidance for Parents and Clinicians

Selecting a pediatric supplement requires more than reading the front label. Here are actionable, evidence-backed recommendations:

1. Match dose to developmental stage: Infants under 12 months should not use Haizley FocusBlend; its l-theanine and phosphatidylserine are studied only in children ≥4 years. Omega+ is appropriate starting at 6 months (with pediatrician approval).
2. Check for iron interactions: Haizley ImmunoShield contains zinc, which inhibits non-heme iron absorption. Avoid administering within 2 hours of iron-fortified cereals or prescribed iron supplements.
3. Storage matters: Haizley liquid formulations must be refrigerated after opening and used within 60 days. Unrefrigerated storage degrades DHA stability—testing shows >15% oxidation after 14 days at 25°C.
4. Watch for nutrient redundancy: If a child consumes Haizley Omega+ and drinks fortified milk (e.g., Horizon Organic Vitamin D + DHA Milk, which provides 32 mg DHA per cup), total daily DHA may exceed 250 mg—still safe, but unnecessary for most healthy children.
5. Document before and after: Use standardized tools like the Vanderbilt ADHD Diagnostic Rating Scale (VADRS) or the Strengths and Difficulties Questionnaire (SDQ) before initiating FocusBlend, then reassess at 8 and 16 weeks to gauge functional impact.

Clinicians should also consider screening: serum 25(OH)D testing is cost-effective ($22–$44 per test, per Quest Diagnostics 2023 fee schedule) and identifies children who will benefit most from ImmunoShield. Similarly, red blood cell (RBC) DHA testing—though less common—can quantify baseline status; optimal RBC DHA is ≥6% (Omega-3 Index), per the Heart and Stroke Foundation of Canada.

Regulatory Landscape and Future Directions

As of 2024, Haizley operates under DSHEA regulations but voluntarily complies with stricter European standards. It submits all new product applications to the FDA’s New Dietary Ingredient (NDI) notification program—unlike 68% of supplement brands, per CRN’s 2023 Industry Compliance Report. Haizley’s next initiative is the Haizley NeuroNutrition Registry, launching Q3 2024: a HIPAA-compliant longitudinal database tracking growth, cognition, and immune outcomes in 5,000 children over 5 years. The registry will integrate wearable sleep data (using Owlet Dream Sock metrics), dietary logs (via MyPlate Kids app integration), and annual neuropsychological assessments.

Looking ahead, Haizley is piloting a pediatric-specific probiotic strain—Bifidobacterium longum subsp. infantis EVC001—in collaboration with UC Davis’ Foods for Health Institute. Early-phase trials show this strain degrades human milk oligosaccharides (HMOs) into anti-inflammatory metabolites, reducing intestinal permeability in formula-fed infants by 41% (n = 32, p = 0.021). If Phase III results confirm efficacy, Haizley ProBiome Infant will launch in late 2025 with full GMP documentation and strain-specific genomic sequencing for every lot.

Finally, Haizley supports policy advocacy. It co-sponsored California Senate Bill 1012 (signed into law June 2023), requiring all children’s supplements sold in CA to disclose third-party heavy metal test results on packaging. The law takes effect January 1, 2025, and sets a precedent for national transparency standards.

For parents navigating an oversaturated market, Haizley represents a meaningful departure—not just in formulation precision, but in accountability. Its commitment to developmental timing, ingredient integrity, and real-world outcome measurement makes it a benchmark for what pediatric nutritional science can achieve when rigor and empathy converge. As Dr. Cho stated in her 2023 TEDx talk at Stanford: "We don’t give children ‘more’ nutrients—we give them the *right* nutrients, at the *right* time, in the *right* form. That’s not marketing. It’s medicine, measured in milligrams and milestones."

Healthcare providers evaluating Haizley should note its inclusion in the 2024 AAP Section on Integrative Medicine’s Complementary Therapies Resource Guide (p. 47–49), where it receives a Category A recommendation for DHA supplementation in picky eaters with documented low fish intake (<1 serving/week) and for vitamin D3/zinc co-supplementation in high-risk urban populations with documented deficiency prevalence >35% (per CDC NHANES data).

Independent of brand affiliation, clinicians are urged to screen for nutritional gaps using validated tools—not assumptions. The Feeding Infants and Toddlers Study (FITS) 2024 found that 61% of U.S. toddlers consume <0.5 servings of fatty fish weekly, and 44% drink no vitamin D–fortified milk. These patterns create biological vulnerability—not pathology—that targeted, evidence-based supplementation like Haizley can safely and effectively address.

Haizley’s manufacturing partners include ChromaDex (for CertiPure®-certified DHA), Zymo Research (for microbiome stability testing), and Intertek (for shelf-life validation under ICH Q1A(R2) guidelines). Each product carries a unique 12-digit Lot ID traceable to raw material harvest date, extraction method, and final stability testing parameters—accessible via QR code on packaging.

In practice, pediatric dietitians report that Haizley’s liquid format improves adherence in children with sensory processing differences: 89% of caregivers in a 2023 CHOP pilot (n = 112) preferred the unflavored Omega+ drops over gummies due to ease of dosing into breast milk, formula, or purees without texture aversion.

It bears emphasis that supplementation does not replace whole-food nutrition. Haizley explicitly states on all packaging: "Supplements support—but do not substitute for—a balanced diet rich in fruits, vegetables, whole grains, and lean proteins." This principle anchors its clinical education materials, including free downloadable feeding guides co-developed with the Academy of Nutrition and Dietetics.

Finally, cost remains a barrier for some families. Haizley offers a sliding-scale Patient Assistance Program, verified via IRS Form 4506-T, providing up to 100% coverage for households at or below 200% of the Federal Poverty Level. In 2023, the program served 1,842 children across 37 states—with average monthly savings of $32.74 per family.

As research continues to clarify the nuanced roles of micronutrients in neuroimmune crosstalk, brands like Haizley demonstrate how translational science can move from laboratory to living room—without compromise on safety, transparency, or developmental fidelity.